世界卫生组织《残疾评定》的制订和测试
姚贵忠 舒良 沈渔邨 北京大学精神卫生研究所 100083
目的:与WHO协作开发一套国际通用的残疾评定工具——WHO残疾评定量表(Disability Assessment Schedule,DAS),测试其在中国应用的信度、效度,初步探讨评残分界值。
方法:
1.与WHO共同制订和测试DAS条目库,并通过多种问卷向残疾者及其家属、专业人员和政策制定者进行残疾状况调查,然后经过对DAS中介版本的测试,制订出DAS最终版本。
2.以中国精神残疾评定标准(SDSS-R)作为效标,2名评定者对254例受试者进行了DAS测试,测试评定者信度20例,测试重测信度100例。
3.纳入50名急性发作期精神分裂症患者,经过8周常规治疗,评定治疗前后DAS对病情变化的敏感性(STC)。
结果: DAS总分及6个因子分的重测相数都在0.9以上,评定者信度(ICC via ANOVA)为0.997,6个因子分之间以及每个因子分与总分之间的相关都具有高度显著性(P值均小于0.01)。因子分析的结果与原量表结构基本相符,各因子贡献率的分布与量表的理论构想是相一致的。DAS与SDSS-R、BPRS、CGI之间的相关都具有高度显著性(P值均小于0.01),提示DAS与三者之间的平行效度良好。经过8周临床治疗,随着BPRS和CGI得分的显著下降,DAS及其5个因子分的下降亦有显著性。本研究以SDSS-R的评分结果为基础,初步设定DAS的评残分界值为:51分以下无残疾,52-94分轻度,95-115分中度,116分以上重度,两种评残方法具有高度一致性(Kappa=0.592, P<0.01)。
结论: DAS的各项信度、效度指标均达到心理测量学要求,可以作为一种新的残疾评定工具使用,它的开发对推动残疾问题的研究意义重大。
————————————
DSM-IV Axis V consisted of the Global Assessment of Functioning (GAF) scale, representingthe clinician's judgment of the individual's overall level of "functioning on a hypotheticalcontinuum of mental health-illness." It was recommended that the GAF bedropped from DSM-5 for several reasons, including its conceptual lack of clarity (i.e., includingsymptoms, suicide risk, and disabilities in its descriptors) and questionable psychometricsin routine practice. In order to provide a global measure of disability, the WHODisability Assessment Schedule (WHODAS) is included, for further study, in Action III ofDSM-5 (see the chapter "Assessment Measures"). The WHODAS is based on the InternationalClassification of Functioning, Disability and Health (ICF) for use across all of medicineand health care. The WHODAS (version 2.0), and a modification developed for children/adolescents and their parents by the Impairment and Disability Study Group were includedin the DSM-5 field trial.
————————————
世界卫生组织残疾评定量表